Published in Exp Eye Res on March 31, 2009
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol (2011) 1.46
Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy. J Ophthalmol (2011) 0.89
Drug delivery to the posterior segment of the eye for pharmacologic therapy. Expert Rev Ophthalmol (2010) 0.85
Emerging role of antioxidants in the protection of uveitis complications. Curr Med Chem (2011) 0.84
A biodegradable, sustained-released, prednisolone acetate microfilm drug delivery system effectively prolongs corneal allograft survival in the rat keratoplasty model. PLoS One (2013) 0.82
Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis. Int Ophthalmol (2013) 0.76
Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide. Invest Ophthalmol Vis Sci (2016) 0.75
Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis (2010) 1.54
Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood (2002) 1.44
Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis. Crit Care (2014) 1.36
Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays. Mod Pathol (2006) 1.27
Applications of nanoparticles in ophthalmology. Prog Retin Eye Res (2010) 1.27
Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf (2013) 1.25
Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci (2003) 1.16
Cytokine and chemokine levels in tears from healthy subjects. Acta Ophthalmol (2010) 1.14
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci (2006) 1.11
Clinical and technical phosphoproteomic research. Proteome Sci (2011) 1.04
Characterization and short-term culture of cells recovered from human conjunctival epithelium by minimally invasive means. Mol Vis (2009) 1.02
Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration. J Control Release (2004) 1.02
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials (2006) 1.00
Building an outcome predictor model for diffuse large B-cell lymphoma. Am J Pathol (2004) 0.99
High tolerance of wild Lactobacillus plantarum and Oenococcus oeni strains to lyophilisation and stress environmental conditions of acid pH and ethanol. FEMS Microbiol Lett (2004) 0.96
In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci (2008) 0.95
A comparison of stem cell-related gene expression in the progenitor-rich limbal epithelium and the differentiating central corneal epithelium. Mol Vis (2011) 0.95
Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD). Curr Eye Res (2012) 0.92
Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium. Invest Ophthalmol Vis Sci (2005) 0.92
Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf (2005) 0.92
Intraocular inflammation as the main manifestation of Rickettsia conorii infection. Clin Ophthalmol (2011) 0.92
Surgical outcomes of uveitic glaucoma. J Ophthalmic Inflamm Infect (2010) 0.91
Cytokine responses by conjunctival epithelial cells: an in vitro model of ocular inflammation. Cytokine (2008) 0.91
Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. Invest Ophthalmol Vis Sci (2013) 0.90
Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. Invest Ophthalmol Vis Sci (2011) 0.90
Cat-scratch disease (ocular bartonellosis) presenting as bilateral recurrent iridocyclitis. Clin Infect Dis (2005) 0.90
Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye. Invest Ophthalmol Vis Sci (2007) 0.89
Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells. Mol Vis (2011) 0.89
Evaluation of ocular surface inflammation in the presence of dry eye and allergic conjunctival disease. Ocul Surf (2005) 0.88
Autoantibodies contribute to the immunopathogenesis of experimental dry eye disease. Invest Ophthalmol Vis Sci (2012) 0.87
Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. Arch Ophthalmol (2006) 0.87
Macular edema as the only ocular finding of tuberculosis. Am J Ophthalmol (2004) 0.87
In vitro simulation of corneal epithelium microenvironment induces a corneal epithelial-like cell phenotype from human adipose tissue mesenchymal stem cells. Curr Eye Res (2013) 0.87
Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres: protective effects of low temperature during gamma-irradiation. Int J Pharm (2006) 0.85
Molecular and cellular biomarkers in dry eye disease and ocular allergy. Curr Opin Allergy Clin Immunol (2012) 0.85
Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure. J Control Release (2011) 0.84
Effect of TGF-β on ocular surface epithelial cells. Exp Eye Res (2012) 0.84
Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles. Cornea (2010) 0.83
Activation of MAPK signaling pathway and NF-kappaB activation in pterygium and ipsilateral pterygium-free conjunctival specimens. Invest Ophthalmol Vis Sci (2011) 0.83
Comparison of gene expression profiles of conjunctival cell lines with primary cultured conjunctival epithelial cells and human conjunctival tissue. Gene Expr (2009) 0.83
Human epithelium from conjunctival impression cytology expresses MUC7 mucin gene. Cornea (2003) 0.83
Conjunctival mucin mRNA expression in contact lens wear. Optom Vis Sci (2009) 0.83
Genetically engineered elastin-like polymer as a substratum to culture cells from the ocular surface. Curr Eye Res (2009) 0.83
Mitochondrial permeability transition pore in inflammatory apoptosis of human conjunctival epithelial cells and T cells: effect of cyclosporin A. Invest Ophthalmol Vis Sci (2013) 0.82
Characterization by Belmonte's gas esthesiometer of mechanical, chemical, and thermal corneal sensitivity thresholds in a normal population. Invest Ophthalmol Vis Sci (2012) 0.82
Reducing hazardous cleaning product use: a collaborative effort. Public Health Rep (2009) 0.82
Discovering and validating unknown phospho-sites from p38 and HuR protein kinases in vitro by Phosphoproteomic and Bioinformatic tools. J Clin Bioinforma (2011) 0.81
Differential cell proliferation, apoptosis, and immune response in healthy and evaporative-type dry eye conjunctival epithelia. Invest Ophthalmol Vis Sci (2011) 0.81
Prevalence of diabetic retinopathy and eye care in a rural area of Spain. Ophthalmic Epidemiol (2002) 0.81
Subretinal fibrosis and uveitis syndrome associated with ulcerative colitis. Int J Colorectal Dis (2006) 0.80
A new device to improve the location of a Montgomery thyroplasty prosthesis. Laryngoscope (2014) 0.79
PRRT2 mutation causes paroxysmal kinesigenic dyskinesia and hemiplegic migraine in monozygotic twins. Eur J Paediatr Neurol (2012) 0.79
Alpha2-adrenergic receptors are present in normal human conjunctiva. Curr Eye Res (2005) 0.79
Tailored recombinant elastin-like polymers for advanced biomedical and nano(bio)technological applications. Biotechnol Lett (2006) 0.79
Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT. Exp Eye Res (2008) 0.79
Antioxidant enzyme mRNA expression in conjunctival epithelium of healthy human subjects. Can J Ophthalmol (2011) 0.78
Comparison of the in vitro tolerance and in vivo efficacy of traditional timolol maleate eye drops versus new formulations with bioadhesive polymers. Invest Ophthalmol Vis Sci (2011) 0.78
[Incidence of nosocomial infections at a neonatal intensive care unit: a six-year surveillance study]. Enferm Infecc Microbiol Clin (2006) 0.78
Cytokines and chemokines in immune-based ocular surface inflammation. Expert Rev Clin Immunol (2008) 0.78
Consecutive expansion of limbal epithelial stem cells from a single limbal biopsy. Curr Eye Res (2013) 0.78
The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analogue, 5-MCA-NAT, in rabbit eyes. Invest Ophthalmol Vis Sci (2011) 0.78
Conjunctival pigmentation in Stevens-Johnson syndrome. Ann Ophthalmol (Skokie) (2007) 0.78
The Cuban Public Registry of Clinical Trials: primary registry of World Health Organization. J Evid Based Med (2011) 0.78
Effects of fibroblast growth factor and glial-derived neurotrophic factor on akinesia, F-DOPA uptake and dopamine cells in parkinsonian primates. Parkinsonism Relat Disord (2002) 0.77
Influence of Climate on Clinical Diagnostic Dry Eye Tests: Pilot Study. Optom Vis Sci (2015) 0.77
Automatic detection of red lesions in retinal images using a multilayer perceptron neural network. Conf Proc IEEE Eng Med Biol Soc (2008) 0.76
Basal values, intra-day and inter-day variations in tear film osmolarity and tear fluorescein clearance. Curr Eye Res (2014) 0.76
Influence of environmental factors in the in vitro dehydration of hydrogel and silicone hydrogel contact lenses. J Biomed Mater Res B Appl Biomater (2013) 0.76
Chitosan-gelatin biopolymers as carrier substrata for limbal epithelial stem cells. J Mater Sci Mater Med (2013) 0.76
Retraction: clinical and technical phosphoproteomic research. Proteome Sci (2013) 0.75
CD44 and RHAMM hyaluronan receptors in human ocular surface inflammation. Graefes Arch Clin Exp Ophthalmol (2014) 0.75
Human conjunctival epithelium in culture: a tool to assay new therapeutic strategies for dry eye. Adv Exp Med Biol (2002) 0.75
Oculopalpebral borreliosis as an unusual manifestation of Lyme disease. Cornea (2013) 0.75
Lack of Agreement among Electrical Impedance and Freezing-Point Osmometers. Optom Vis Sci (2016) 0.75
Corneal Sensitivity and Inflammatory Biomarkers in Contact Lens Discomfort. Optom Vis Sci (2016) 0.75
INFLUENCE OF MECHANICAL VENTILATION ON VANCOMYCIN PHARMACOKINETICS ADMINISTERED BY CONTINUOUS INFUSION IN CRITICALLY ILL PATIENTS. Antimicrob Agents Chemother (2017) 0.75
Effect of Environmental Conditions on the Concentration of Tear Inflammatory Mediators During Contact Lens Wear. Cornea (2016) 0.75
Distinctive clinical features of idiopathic versus infectious serpiginous choroidopathy. Ocul Immunol Inflamm (2012) 0.75
Muscarinic receptors in the ocular surface. Curr Opin Allergy Clin Immunol (2006) 0.75
Fatal disseminated Scedosporium prolificans infection initiated by ophthalmic involvement in a patient with acute myeloblastic leukemia. Diagn Microbiol Infect Dis (2013) 0.75
Recent patents and developments in glaucoma biomarkers. Recent Pat Endocr Metab Immune Drug Discov (2012) 0.75
Contact lens case cleaning procedures affect storage solution pH and osmolality. Optom Vis Sci (2011) 0.75
Effects of the External Environment on Dry Eye Disease. Int Ophthalmol Clin (2017) 0.75
Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats. Curr Eye Res (2002) 0.75
Can pharmacogenetics help patients under chronic treatment with coumarin anticoagulants? Drug Metabol Personal Ther (2016) 0.75
Conjunctival pigmentation in Stevens-Johnson syndrome. Compr Ther (2007) 0.75